Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-04

Clinical Trial Update: A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation [Phase 3]

View source ↗

Summary

This Phase 3 study evaluated the safety and efficacy of 0.5% ivermectin cream versus vehicle in treating Pediculosis capitis (head lice); the trial has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ivermectin cream 0.5% (ivermectin)

Snippet

Sponsor: Topaz Pharmaceuticals Inc | Conditions: Head Lice | Phase 3 | Status: COMPLETED | Results posted: 2012-04-04